{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:47:36Z","timestamp":1775713656445,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vph.2024.107441","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T21:02:28Z","timestamp":1732309348000},"page":"107441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran"],"prefix":"10.1016","volume":"157","author":[{"given":"Reza Golchin","family":"Vafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein Molavi","family":"Vardanjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Kojuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.vph.2024.107441_bb0005","first-page":"716","article-title":"The treatment of coronary artery disease: current status six decades after the first bypass operation","volume":"119","author":"Doenst","year":"2022","journal-title":"Dtsch. Arztebl. Int."},{"issue":"5","key":"10.1016\/j.vph.2024.107441_bb0010","first-page":"72","article-title":"Postoperative care and follow-up after coronary stenting","volume":"110","author":"Rassaf","year":"2013","journal-title":"Dtsch. Arztebl. Int."},{"issue":"2","key":"10.1016\/j.vph.2024.107441_bb0015","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Members","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"suppl_G","key":"10.1016\/j.vph.2024.107441_bb0020","doi-asserted-by":"crossref","first-page":"G35","DOI":"10.1093\/eurheartj\/sul053","article-title":"Drug interactions in the setting of acute coronary syndromes and dual anti-platelet therapy","volume":"8","author":"Bassand","year":"2006","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.vph.2024.107441_bb0025","series-title":"Drug Utilization Research","first-page":"381","article-title":"Interventions to improve adherence to drug treatment","author":"Schneider","year":"2016"},{"issue":"3","key":"10.1016\/j.vph.2024.107441_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2011.38","article-title":"Patient medication adherence: measures in daily practice","volume":"26","author":"Jimmy","year":"2011","journal-title":"Oman Med. J."},{"key":"10.1016\/j.vph.2024.107441_bb0035","first-page":"1617","article-title":"Patient adherence: a \u201crisk factor\u201d for cardiovascular disease. The Framington Study","volume":"215","author":"Leupkar","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2024.107441_bb0040","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2147\/PPA.S268499","article-title":"Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions","volume":"14","author":"Elnaem","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"11","key":"10.1016\/j.vph.2024.107441_bb0045","first-page":"Cd000011","article-title":"Interventions for enhancing medication adherence","volume":"2014","author":"Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.vph.2024.107441_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/fcp.12727","article-title":"Chronic polypharmacy at all age: a population-based drug utilization study","volume":"36","author":"Guillot","year":"2022","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2024.107441_bb0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00019053-199405040-00005","article-title":"Drug utilisation studies as tools in health economics","volume":"5","author":"Sacrist\u00e9n","year":"1994","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.vph.2024.107441_bb0060","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.clinthera.2010.06.010","article-title":"The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran","volume":"32","author":"Namazi","year":"2010","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.vph.2024.107441_bb0065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pec.2021.05.030","article-title":"The influence of patient expectations on adherence to treatment regimen after myocardial infarction","volume":"105","author":"Pietrzykowski","year":"2022","journal-title":"Patient Educ. Couns."},{"issue":"1","key":"10.1016\/j.vph.2024.107441_bb0070","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12872-023-03192-0","article-title":"Ethnic differences in the lifestyle behaviors and premature coronary artery disease: a multi-center study","volume":"23","author":"Babahajiani","year":"2023","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.vph.2024.107441_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2024.107441_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287306","article-title":"Related variations: a novel approach for detecting patterns of regional variations in healthcare utilisation rates","volume":"18","author":"Rudolfsen","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vph.2024.107441_bb0085","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/14740338.2021.1928632","article-title":"Trends and concerns of potentially inappropriate medication use in patients with cardiovascular diseases","volume":"20","author":"Anfinogenova","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.vph.2024.107441_bb0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-030-32004-1_7","article-title":"Medications used for the cardiovascular system","author":"Adams","year":"2020","journal-title":"Understanding Pharmacol. Nursing Pract."},{"issue":"9","key":"10.1016\/j.vph.2024.107441_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.9734\/jammr\/2020\/v32i930490","article-title":"Evaluation of drug utilization pattern in cardiovascular diseases using WHO\/INRUD prescribing indicators at cardiology OPD of tertiary care hospitals in South India: a multicenter cross-sectional study","volume":"32","author":"Veeramani","year":"2020","journal-title":"J. Adv. Med. Med. Res."},{"key":"10.1016\/j.vph.2024.107441_bb0100","series-title":"Study on Drug Utilization Pattern in Cardiology Outpatient Department at Tertiary Care Hospitals in South India: A Prospective Multicenter Cross-Sectional Observational Study","author":"Veeramani","year":"2020"},{"key":"10.1016\/j.vph.2024.107441_bb0105","series-title":"Drug Utilization Pattern in Cardiovascular Conditions of Outpatients at a Tertiary Care Hospital in Gujarat","author":"Raval","year":"2024"},{"issue":"4","key":"10.1016\/j.vph.2024.107441_bb0110","article-title":"Prescribing pattern of cardiovascular drugs-a prospective observational study","volume":"10","author":"Thomas","year":"2017","journal-title":"Indian J. Pharm. Pract."},{"issue":"4","key":"10.1016\/j.vph.2024.107441_bb0115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.5455\/2319-2003.ijbcp20140833","article-title":"Trends in drug usage among elderly with cardiovascular diseases","volume":"3","author":"Shastry","year":"2014","journal-title":"Int. J. Basic Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2024.107441_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/medicines10040026","article-title":"Comorbidity patterns in patients at cardiovascular hospital admission","volume":"10","author":"Soysaler","year":"2023","journal-title":"Medicines"},{"issue":"4","key":"10.1016\/j.vph.2024.107441_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.hroo.2022.06.003","article-title":"Anticoagulation in new-onset postoperative atrial fibrillation: an analysis from the Society of Thoracic Surgeons Adult Cardiac Surgery Database","volume":"3","author":"Riad","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.vph.2024.107441_bb0130","first-page":"10","article-title":"Potential drug-drug interactions of cardiovascular drugs based on literature in geriatric patients with congestive heart failure at Dr. M. Djamil Padang Hospital","volume":"vol. 9","author":"Permatasari","year":"2024","journal-title":"Interactions"},{"issue":"3","key":"10.1016\/j.vph.2024.107441_bb0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.55544\/jrasb.1.3.20","article-title":"To identify drug-drug interaction in cardiac patients in tertiary care hospitals","volume":"1","author":"Sultana","year":"2022","journal-title":"J. Res. Appl. Sci. Biotechnol."},{"issue":"1","key":"10.1016\/j.vph.2024.107441_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/00185787231182569","article-title":"Assessment of potential drug-drug interactions (pDDIs) and their risk factors among hospitalized cardiac patients in a tertiary-care Center of Central India: a retrospective record-based study","volume":"59","author":"Sahoo","year":"2024","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.vph.2024.107441_bb0145","first-page":"27(2)","article-title":"Detection and analysis of potential drug-drug interactions among patients admitted to the cardiac care unit in a tertiary care hospital","author":"Khaled","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.vph.2024.107441_bb0150","series-title":"Proton Pump Inhibitors and Clopidogrel: Putting the Interaction in Perspective","first-page":"2310","author":"Juurlink","year":"2009"},{"issue":"3","key":"10.1016\/j.vph.2024.107441_bb0155","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40801-023-00373-3","article-title":"Potentially harmful drug\u2013drug interactions and their associated factors among hospitalized cardiac patients: a cross-sectional study","volume":"10","author":"Kalash","year":"2023","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.vph.2024.107441_bb0160","series-title":"A Study of Clinically Significant Potential Drug-Drug Interactions and their Risk Factors among Hospitalized Cardiac Patients","author":"Sahoo","year":"2023"},{"issue":"1","key":"10.1016\/j.vph.2024.107441_bb0165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s12872-022-02872-7","article-title":"Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the pars cohort study from Iran","volume":"22","author":"Mohsenzadeh","year":"2022","journal-title":"BMC Cardiovasc. Disord."},{"issue":"02","key":"10.1016\/j.vph.2024.107441_bb0170","article-title":"Polypharmacy and potential drug-drug interactions in adult outpatients receiving cardiovascular drugs","volume":"13","author":"Manjul","year":"2023","journal-title":"Nat. J. Physiol. Pharm. Pharmacol."},{"key":"10.1016\/j.vph.2024.107441_bb0175","first-page":"1","article-title":"Clinical pharmacist interventions in cardiovascular disease pharmacotherapy in elderly patients on excessive polypharmacy: a retrospective pre-post observational multicentric study","author":"Stuhec","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.vph.2024.107441_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-021-02183-0","article-title":"Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States","volume":"21","author":"Sheikh-Taha","year":"2021","journal-title":"BMC Geriatr."},{"issue":"6","key":"10.1016\/j.vph.2024.107441_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/geriatrics7060141","article-title":"Polypharmacy patterns in multimorbid older people with cardiovascular disease: longitudinal study","volume":"7","author":"Vill\u00e9n","year":"2022","journal-title":"Geriatrics"},{"issue":"4","key":"10.1016\/j.vph.2024.107441_bb0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ehjcvp\/pvac005","article-title":"Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on cardiovascular pharmacotherapy","volume":"8","author":"Tamargo","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.vph.2024.107441_bb0195","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.amjcard.2022.01.012","article-title":"Healthcare expenditure associated with polypharmacy in older adults with cardiovascular diseases","volume":"169","author":"Kwak","year":"2022","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2024.107441_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14740\/cr991","article-title":"Polypharmacy is associated with accelerated deterioration of renal function in cardiovascular outpatients","volume":"11","author":"Sakamoto","year":"2020","journal-title":"Cardiol. Res."},{"issue":"1","key":"10.1016\/j.vph.2024.107441_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/bimj.202100237","article-title":"A comparison of full model specification and backward elimination of potential confounders when estimating marginal and conditional causal effects on binary outcomes from observational data","volume":"66","author":"Luijken","year":"2024","journal-title":"Biom. J."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124001678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124001678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T20:24:54Z","timestamp":1737836694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189124001678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"alternative-id":["S1537189124001678"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107441","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107441"}}